Header image of Biologically active materials

Biologically active materials

Bioactive materials that interact with human cell tissue have beneficial effects in many therapeutic applications from wound management to implantable medical devices and synthetic tissue grafts.

Program (1)

Tuesday, 10 September 2019

Personalized skin: fast track to innovation

13:34 - 13:57, Bühne A

Show more

Personalized skin: fast track to innovation

Every year more than 50 million people suffer from skin defects and need skin transplantation to restore skin function. Unfortunately, standard of care is often scarce and non effective leaving these patients with scars. Scars are disfiguring but also highly comforting, they can impair growth and movement and require serial surgeries and intense homecare. Often, psych-social rehabilitation too. CUTISS can now offer a solution: personalized, bioengineered skin grafts that can be produced in large quantities from a small biopsy and that due their biological characteristics will minimally scar after transplantation. Burn victim, burn survivors and all patients in need for skin could now finally have an option. Skin though is our largest organ. It takes more than clinical validation (ongoing phase II) to reach out to patients. This is why we are working on the the scale up already and trying to convert the actual manual production process into an automated one. denovoSkin, our first in line product, is envisioned to be the first-in class automatically produces personalized skin tissue therapy: safe, effective and accessible.

 

Short CV Speaker

Daniela Marino, CEO and co-founder of CUTISS, studied biotechnology in Milan (Italy) and got her PhD of Sciences at the ETHZ. After her post doc at the UZH in tissue engineering, she decided to found the start up to develop the product fast forward towards commercialization.


About the topic

Bioactive materials that interact with human cell tissue have beneficial effects in many therapeutic applications from wound management to implantable medical devices and synthetic tissue grafts.

Share this page